---
document_datetime: 2026-01-23 09:06:10
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/byooviz-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: byooviz-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.1308204
conversion_datetime: 2026-01-26 20:53:46.877877
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.70.0
  docling-core: 2.60.2
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Byooviz

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0016/G            | This was an application for a group of variations. B.II.e.1.b.2 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Sterile medicinal products and biological/immunological medicinal products | 27/11/2025                          |                                             | SmPC, Labelling and PL           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                           |            |     |    |                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|-----------------------|
| N/0019    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                 | 12/09/2024 |     | PL |                       |
| IB/0018/G | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 22/05/2024 | n/a |    | material/intermediate |
| N/0017    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                 | 19/04/2024 |     | PL |                       |
| IB/0015/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation          | 07/02/2024 | n/a |    |                       |
| N/0014    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                 | 11/01/2024 |     | PL |                       |

<div style=\"page-break-after: always\"></div>

| II/0012/G          | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.2.b - Changes in the manufacturing process of the AS - Substantial change to the manufacturing process of the AS which may have a significant impact on the quality, safety or efficacy of the medicinal product   | 05/10/2023   | n/a        |             |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-----------------------------------|
| IA/0013            | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                            | 02/08/2023   | n/a        |             |                                   |
| PSUSA/2609/ 202210 | Periodic Safety Update EU Single assessment - ranibizumab                                                                                                                                                                                                                                                                                                                               | 12/05/2023   | n/a        |             | PRAC Recommendation - maintenance |
| IB/0010            | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                                                                                                                                                                                                                | 21/02/2023   | 07/12/2023 | SmPC and PL |                                   |
| IA/0011            | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                     | 16/01/2023   | n/a        |             |                                   |
| IB/0007            | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                                                                                                     | 04/01/2023   | 07/12/2023 | SmPC        |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0008   | B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                      | 16/12/2022   | n/a        |                        |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| IB/0006   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 15/12/2022   | 07/12/2023 | SmPC and PL            |
| IB/0005   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                | 10/11/2022   | n/a        |                        |
| IB/0004   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                  | 05/10/2022   | n/a        |                        |
| IB/0003   | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                          | 11/04/2022   | 29/09/2022 | SmPC                   |
| IAIN/0002 | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes                                                           | 12/10/2021   | 29/09/2022 | SmPC, Labelling and PL |